Latest filing published 31 Mar 2022 for MusclePharm Corp.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by White Winston Select Asset Fund Series Fund MP-18, LLC on record concern MusclePharm Corp. In total, 5 filings cover trades dated from 27 September 2019 to 29 March 2022.
The open-market side counts 4 purchases alongside 1 sale. The amount is not disclosed for 5 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show no purchases and 1 sale.
On 31 March 2022 came the latest disclosure, an open-market sale in MusclePharm Corp. The latest purchase dates back some time: it was published 2,542 days ago, on 8 November 2019. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration